Residential
Osorio De Gibbs, Sarai
Osorio De Gibbs, Sarai was paid $8.47M by Medicaid between Feb 2021 and Dec 2024, across 10 billing codes. Its largest line is H2016, community support for mental illness or disability, billed per day — 37% of everything it billed.
33Billing provider infoOSORIO DE GIBBS, SARAI
HOUSTON, TX 77036
HOUSTON, TX 77036
33aNPI1982867289assigned 07/07/2008
33bProvider typeIntellectual and/or Developmental Disabilities Community Based Residential Treatment Facility
28Total paid$8.47M
24GClaims88,403
24DCodes billed10
24AFirst – last monthFeb 2021 – Dec 2024
Compared with peers
Next to other Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility providers in Texas
Rank by total paid#40 of 115
Median peer was paid$5.61M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 9,526 | $1.09M | |
| 2022 | 21,030 | $2.00M | |
| 2023 | 26,449 | $2.41M | |
| 2024incomplete | 31,398 | $2.97M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H2016 | Community support for mental illness or disability, billed per dayComprehensive community support services, per diem | 37% | 38,360 | 1,307 | $3.12M |
| T2016 | A day of residential support for a person with a developmental disabilityHabilitation, residential, waiver; per diem | 26% | 15,976 | 745 | $2.21M |
| S5150 | Respite care, billed per 15 minutesUnskilled respite care, not hospice; per 15 minutes | 10% | 5,370 | 701 | $861K |
| M0360 | 8.7% | 5,607 | 267 | $741K | |
| H2014 | Skills training and development, per 15 minutes | 6.9% | 10,503 | 523 | $582K |
| M0123 | 5.3% | 5,899 | 245 | $449K | |
| M0240 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses | 3.6% | 1,782 | 250 | $301K |
| T2020 | Day habilitation, waiver; per diem | 2.0% | 4,506 | 230 | $173K |
| T1002 | Rn services, up to 15 minutes | <1% | 382 | 263 | $28K |
| M0299 | <1% | 18 | 12 | $4K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.